Showing posts with label positive results. Show all posts
Showing posts with label positive results. Show all posts

Exercise may not be high on your radar when it comes to commitment, but you may be more inclined to hit the gym when you discover this interesting fact: exercise can offer a number of health benefits, and it also improves your sex life. For example, it helps to lower the risk of erectile dysfunction by opening the arteries which supply the blood flow to your penis. In a study carried out by the Harvard School of Public Health of more than 31,000 men who were over the age of 50, those who were physically active were less likely to be impotent than those who weren’t. Even moderate levels of exercise can help to offer such benefits, such as a brisk 30-minute walk each day of the week. Research has even shown that exercise can reverse the symptoms of ED. Physically active men also have fewer symptoms of an enlarged prostate than men who don’t exercise. Men with BPH often feel the need to urinate more frequently or have a weak stream or urine, but exercise can cut their risk of developing of this by simply keeping fit. There’s no exercise in particular which works best for BPH, but getting 30 minutes of solid exercise most days of the week is often enough to see positive results. If you’re trying to have kids, or think you may want to in the future, keeping fit is vital for the quality of your semen – a recent study showed that men who work out at least 15 hours a week had higher sperm counts than inactive men. So if you’re more inclined to lift the TV remote than a dumbbell, you may want to change your habits. Men who watched more than 20 hours of TV a week had significantly lower sperm counts than men who watched no TV – something to consider for men who want a family!


 


Of course, it’s not just your health to consider (although that’s a pretty important factor). There’s also your ability in the bedroom itself. When it comes to the strict matter of sex, fitter men have the advantage over couch potatoes. Men in good shape will find sex easier and less painful than men who don’t exercise very much. For example, you’ll notice the effects after having sex in your abdominal muscles and your hips. But if you exercise regularly, these effects won’t be noticed as the muscles will already be stronger and more flexible. Likewise, if you’re partial to the missionary position, you may find that your chest muscles are achey after sex. Exercise not only lowers the risk of a muscular injury after a particularly passionate sex session, but it also helps you to feel more confident and energised both in and out of the bedroom. This can improve your sex life significantly, as you’ll feel good about yourself which can improve both how you see yourself and how your partner sees you. You’ll be more relaxed and less distracted, as well as less likely to suffer sexual problems, as stated above. The best exercise routine for a great sex life is a well-rounded regimen which sees you improve your strength, cardio and flexibility training. So if you want to become a better lover, as well as healthier in the process, it seems the answer is simple – hit the gym on a regular basis and you’ll be seeing positive results in no time.





COPDA positive batch of late-stage trial data has put Spanish drug manufacturer Almirall and US group Forest Laboratories one step closer to improving COPD wellness. The company has announced the results of their study, which indicates they are close to filling their chronic obstructive pulmonary disease (COPD) inhaler Genuair with regulators which could greatly improve COPD sufferers’ wellbeing.


Genuair delivers a fixed dose of alclidinium bromide and formoterol fumarate, which are two different bronchodilators with different modes of action. The doses of aclidinium/formoterol tested were 400/6mcg and 400/12mcg, taken twice a day. According to the group, both of the bronchodilators made their primary endpoints during the pivotal six-month Phase III clinical trial of Genuair (also known as Pressair).


The study researchers boasted that both doses of the aclidinium/formoterol combination showed statistically significant improvements in lung function. This was measured by change from baseline in morning pre-dose through FEV1, and compared with formoterol 12mcg and in FEV1 at one hour post-dose versus aclidinium 400mcg. The study researchers also noted that both treatment arms were well tolerated in the study, although nasopharyngitis and back pain were the most common side effects experienced.




A second Phase III trial is now underway, the results of which are expected over the coming weeks. If this second trial produces positive results, the groups will have the support they need to file a New Drug Application with regulators on both sides of the pond. According to Bertil Lindmark, Chief Scientific Officer at Almirall, ‘We expect this novel combination of aclidinium/formoterol to offer patients a new option in COPD treatment. In addition to the improved efficacy shown in this study, the safety profile was comparable to placebo.’


The World Health Organisation (WHO) calls COPD as a global epidemic, with an estimated 64 million people suffering from the condition around the world. Chronic obstructive pulmonary disease is common, progressively debilitating your lungs through persistent airflow limitation that makes it hard to breathe. Therefore, a new treatment which could effectively reduce the symptoms of COPD is always welcome, and this study may provide new hope for millions of sufferers worldwide.







Innovative COPD Drug Produces Positive Results in Trials